Skylight Health Group (SLHG)
NASDAQ:SLHG

Skylight Health Group Stock Analysis & Ratings

Skylight Health Group Stock Analysis Overview

Smart Score
5
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
The Skylight Health Group stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Stock Chart

SLHG

SLHG Stock Stats

Previous Close$0.98
Open$0.95
Bid0.9 x 5
Ask0 x 0
Today’s Range$0.9 - $1
52-Week Range$0.90 - $6.25
Volume114.08K
Average Volume262.74K
Market Cap$35.79M
Beta4.78
P/E Ratio-2.6
EPS-0.36
Earnings DateMay 03, 2022

Company Description

Skylight Health Group

CB2 Insights Inc has a mission to mainstream medical cannabis into traditional healthcare by gathering data and creating objective real-world evidence through proprietary software and service brands. Using clinical management and data collection software at the point-of-care, the company and its group of sub-brands has become a force behind bringing traditional healthcare protocols to the rapidly evolving cannabis industry.
Sector
Technology
Industry
Healthcare Providers & Services
CEO
Pradyum Sekar
Employees
80
Website
www.skylight.health
ISIN
CA83086L2057
Address
5520 Explorer Drive, Mississauga, ON, L4W 5L1, CA

Financials


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

SLHG FAQ

What was Skylight Health Group’s price range in the past 12 months?
Skylight Health Group lowest stock price was $0.90 and its highest was $6.25 in the past 12 months.
    What is Skylight Health Group’s market cap?
    Skylight Health Group’s market cap is $35.79M.
      What is Skylight Health Group’s price target?
      The average price target for Skylight Health Group is $4.06. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $5.56 ,the lowest forecast is $2.55. The average price target represents 341.30% Increase from the current price of $0.92.
        What do analysts say about Skylight Health Group?
        Skylight Health Group’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
          When is Skylight Health Group’s upcoming earnings report date?
          Skylight Health Group’s upcoming earnings report date is May 03, 2022 which is in 101 days.
            How were Skylight Health Group’s earnings last quarter?
            Skylight Health Group released its earnings results on Nov 15, 2021. The company reported -$0.072 earnings per share for the quarter, the consensus estimate of -$0.072 by $0.
              Is Skylight Health Group overvalued?
              According to Wall Street analysts Skylight Health Group’s price is currently Undervalued.
                Does Skylight Health Group pay dividends?
                Skylight Health Group does not currently pay dividends.
                What is Skylight Health Group’s EPS estimate?
                Skylight Health Group’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Skylight Health Group have?
                Skylight Health Group has 38,900,000 shares outstanding.
                  What happened to Skylight Health Group’s price movement after its last earnings report?
                  Skylight Health Group reported an EPS of -$0.072 in its last earnings report, expectations of -$0.072. Following the earnings report the stock price went down -13.389%.
                    Which hedge fund is a major shareholder of Skylight Health Group?
                    Currently, no hedge funds are holding shares in SLHG

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis